Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in ...

Welcome to the fourth-quarter 2024 ConocoPhillips earnings conference call. My name is Liz, and I will be your operator for today's call. I will now turn the call over to Phil Gresh, vice ...

ConocoPhillips (COP) came out with quarterly earnings of $1.98 per share, beating the Zacks Consensus Estimate of $1.90 per share. This compares to earnings of $2.40 per share a year ago.

NEW ORLEANS — Survivors of Catholic clergy abuse and their supporters expressed disgust, pain and disbelief in the wake of WWL Louisiana and the Guardian’s investigation Monday into hundreds ...

which acts as a PDE4 inhibitor. Results from the POETYK PSO-1 and POETYK PSO-2 showed that 58% and 53% respectively of patients treated with Sotyktu achieved 75% skin clearance, versus 35% and 40% ...

PDE4 inhibitors specifically prevent the hydrolysis of cAMP and have a broad spectrum of anti-inflammatory effects. Roflumilast is a highly selective phosphodiesterase (PDE)-4 inhibitor with ...

The Current22:26How a camera opened Eldred Allen’s eyes to Labrador’s beauty Photographer Eldred Allen says picking up a camera for the first time in 2018 made him look at the world in a ...

Several DPP-4 inhibitors are in clinical development; these are orally active and increase levels of active GLP-1, which in turn increases insulin secretion and reduces glucagon secretion and ...

Pfizer also got the nod for Staquis (crisaborole), a topical phosphodiesterase 4 (PDE-4) inhibitor for atopic dermatitis already sold as Eucrisa in the US since 2016. The US drugmaker also had a ...

Negotiating a higher salary may make you feel like you're overstepping or asking for too much. But the reality is that standing up for what you deserve is perfectly acceptable and even expected in ...

After hours: 7 February at 19:59:00 GMT-5 ...